Zelira Therapeutics Receives AU$919,000 Funding Under Australian Government's R&D Tax Incentive Scheme
Zelira Therapeutics Receives AU$919,000 Funding Under Australian Government's R&D Tax Incentive Scheme
Zelira Therapeutics根據澳大利亞政府的研發稅收優惠計劃獲得91.9萬澳元的資助
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊